Incorporation of analog purine nucleosides into the formed elements of human blood: erythrocytes, platelets, and lymphocytes.
D000241:Adenosine / Q000031:analogs & derivatives / Q000097:blood; D000243:Adenosine Deaminase / Q000378:metabolism; D001792:Blood Platelets / Q000378:metabolism*; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism*; D005573:Formycins / Q000494:pharmacology; D006147:Guanine / Q000031:analogs & derivatives / Q000097:blood; D006151:Guanosine / Q000031:analogs & derivatives / Q000097:blood; D006160:Guanosine Triphosphate / Q000096:biosynthesis; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000201:enzymology; D008214:Lymphocytes / Q000201:enzymology / Q000378:metabolism*; D010974:Platelet Aggregation / Q000187:drug effects; D011684:Purine Nucleosides / Q000097:blood*; D012265:Ribonucleotides / Q000096:biosynthesis; D013329:Structure-Activity Relationship
D005573:Formycins; D011684:Purine Nucleosides; D012265:Ribonucleotides; D006151:Guanosine; D006147:Guanine; D006160:Guanosine Triphosphate; D000243:Adenosine Deaminase; D000241:Adenosine